Effects of BA.1/BA.2 subvariant, vaccination and prior infection on infectiousness of SARS-CoV-2 omicron infections

J Travel Med. 2022 Sep 17;29(6):taac068. doi: 10.1093/jtm/taac068.
No abstract available

Keywords: COVID-19; Omicron; breakthrough infection; epidemiology; immunity; sub-lineage; subvariant; vaccine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Viral
  • COVID-19* / prevention & control
  • Humans
  • SARS-CoV-2
  • Vaccination

Substances

  • Antibodies, Viral